-
B8261-25 g
Thomas Scientific
BK/SK, Kv1, Kv3, TASK-2 K+ channel and voltage-gated Na+ channel blocker used as an anesthetic. It may be neurotoxic at high doses, inducing apoptosis in neuroblastoma cells. (C08-0489-445)
Price: $568.27List Price: $631.42Bupivacaine is an amino amide anesthetic that decreases current amplitude and inhibits whole cell K+ currents in Ca2+-activated (BK/SK) K+ channels and N-type voltage-gated (Kv1/shaker and Kv3 KCNA/KCNC) K+ channels. Bupivacaine also inhibits -
13877-1A glycopeptide antitumor antibiotic that produces single and double-strand DNA breaks in tumor cells to interrupt their cell cycle has been used for the treatment of Hodgkin&rsquos lymphoma in combination with doxorubicin, squamous cell
-
13877-10A glycopeptide antitumor antibiotic that produces single and double-strand DNA breaks in tumor cells to interrupt their cell cycle has been used for the treatment of Hodgkin&rsquos lymphoma in combination with doxorubicin, squamous cell
-
13877-5A glycopeptide antitumor antibiotic that produces single and double-strand DNA breaks in tumor cells to interrupt their cell cycle has been used for the treatment of Hodgkin&rsquos lymphoma in combination with doxorubicin, squamous cell
-
13877-50A glycopeptide antitumor antibiotic that produces single and double-strand DNA breaks in tumor cells to interrupt their cell cycle has been used for the treatment of Hodgkin&rsquos lymphoma in combination with doxorubicin, squamous cell
-
16480-10A mixed antagonist at dopamine D2, D3, and serotonin 5-HT2A receptors (Kis = 0.14, 0.
-
16480-100A mixed antagonist at dopamine D2, D3, and serotonin 5-HT2A receptors (Kis = 0.14, 0.
-
16480-25A mixed antagonist at dopamine D2, D3, and serotonin 5-HT2A receptors (Kis = 0.14, 0.
-
16480-5A mixed antagonist at dopamine D2, D3, and serotonin 5-HT2A receptors (Kis = 0.14, 0.
-
18405-1A selective inhibitor of FGFR4 (IC<sub>50</sub>s = 3, 591, 493, and 150 nM for FGFR4, 1, 2, and 3, respectively) inhibits proliferation of HCC cells (EC<sub>50</sub>s = 0.02-0.
-
18405-10A selective inhibitor of FGFR4 (IC<sub>50</sub>s = 3, 591, 493, and 150 nM for FGFR4, 1, 2, and 3, respectively) inhibits proliferation of HCC cells (EC<sub>50</sub>s = 0.02-0.
-
18405-25A selective inhibitor of FGFR4 (IC<sub>50</sub>s = 3, 591, 493, and 150 nM for FGFR4, 1, 2, and 3, respectively) inhibits proliferation of HCC cells (EC<sub>50</sub>s = 0.02-0.